Polycyclic aromatic hydrocarbon components contribute to the mitochondria-antiapoptotic effect of fine particulate matter on human bronchial epithelial cells via the aryl hydrocarbon receptor.
Study subjects
16HBE14o- human bronchial epithelial cell line
Oxidative stress assays
Superoxide anion generation and apoptosis hallmarks in 16HBE cells exposed to PM2.5-AW alone
Dose-response (1-50 ug/cm2) and kinetic (24, 48, 72 h) exposure of subconfluent 16HBE cells to Auteuil-Winter PM2.5, read out by flow cytometry for mitochondrial depolarization, superoxide anion generation, phosphatidylserine exposure and plasma membrane permeabilization. Hydrogen peroxide served as the positive control. None of the apoptotic parameters rose significantly at any dose or time point. The paper reports no numeric values for these panels (Figure 1A and 1B only), so no measurement slots are filled.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Untreated culture medium, 24 hours (control) EXPOSURE:ferecatu-untreated-24h |
— | — | 24 hour |
| PM2.5-AW 1-50 ug/cm2 for 24 hours (dose-response series) EXPOSURE:ferecatu-pm25aw-1to50-24h |
fine respirable suspended particulate matter ENVO:01000415 |
microgram per square centimeter (range 1 to 50) | 24 hour |
| PM2.5-AW 1-50 ug/cm2 for 48 hours (kinetic series) EXPOSURE:ferecatu-pm25aw-1to50-48h |
fine respirable suspended particulate matter ENVO:01000415 |
microgram per square centimeter (range 1 to 50) | 48 hour |
| PM2.5-AW 1-50 ug/cm2 for 72 hours (kinetic series) EXPOSURE:ferecatu-pm25aw-1to50-72h |
fine respirable suspended particulate matter ENVO:01000415 |
microgram per square centimeter (range 1 to 50) | 72 hour |
| Hydrogen peroxide 500 uM for 24 hours (positive control for apoptosis) EXPOSURE:ferecatu-h2o2-500-24h |
hydrogen peroxide CHEBI:16240 |
500 micromolar | 24 hour |
Outputs
| Group | Output | Description |
|---|---|---|
| control | Untreated 16HBE control OX:ferecatu-pm25-alone-16hbe-output-control · under EXPOSURE:ferecatu-untreated-24h |
|
| treated | 16HBE exposed to PM2.5-AW 1-50 ug/cm2 for 24 hours OX:ferecatu-pm25-alone-16hbe-output-pm25 · under EXPOSURE:ferecatu-pm25aw-1to50-24h |
|
| treated | 16HBE exposed to PM2.5-AW 1-50 ug/cm2 for 48 hours OX:ferecatu-pm25-alone-16hbe-output-pm25-48h · under EXPOSURE:ferecatu-pm25aw-1to50-48h |
|
| treated | 16HBE exposed to PM2.5-AW 1-50 ug/cm2 for 72 hours OX:ferecatu-pm25-alone-16hbe-output-pm25-72h · under EXPOSURE:ferecatu-pm25aw-1to50-72h |
|
| treated | 16HBE exposed to hydrogen peroxide (positive control) OX:ferecatu-pm25-alone-16hbe-output-h2o2 · under EXPOSURE:ferecatu-h2o2-500-24h |
Evidence
epithelial cells to increasing amount of PM 2.5-AW from 1 to 50 μg/cm2.
Gives the exposure series this assay records: PM2.5-AW from 1 to 50 ug/cm2 on 16HBE cells.
2 μM hydroethidine (HE, Molecular Probes) for superoxide anion generation
Identifies the ROS probe and concentration recorded in ros_probe_type.
16HBE cells were exposed to PM 2.5-AW (1 to 50 μg/cm2)o rH 2O2 (500 μM) for 48 h or 72 h
Gives the 48 h and 72 h kinetic conditions recorded above, alongside the hydrogen peroxide positive control.
even when 16HBE cells were exposed for longer times to PM 2.5-AW (1-50 μg/cm2), no significative increase of apoptotic parameters was observed
The assay's result: no significant rise in any apoptotic parameter, including superoxide anion generation, at any dose out to 72 h.
In this study, we showed that low levels of Parisian PM2.5 are not cytotoxic for three different cell lines and primary cultures of human bronchial epithelial cells.
The paper's own summary of this negative cytotoxicity result across all four bronchial epithelial models.
Superoxide anion generation in 16HBE cells pretreated with PM2.5-AW before A23187-induced apoptosis
Subconfluent 16HBE cells received a 4 h PM2.5-AW pretreatment (10 ug/cm2 standard dose; 1-50 ug/cm2 in the dose-response arm) and were then exposed to the calcium ionophore A23187 for a further 20 h. Apoptosis was quantified simultaneously on four flow-cytometry parameters, ROS production (HE -> Eth high) among them. PM2.5 pretreatment reduced the A23187 response by 35% on the DiOC6(3)-low readout and likewise lowered the downstream ROS production. The paper gives no numeric ROS values (Figures 2 and 3 only), so no measurement slots are filled; the percent reductions it does report are on the unmodelled DiOC6(3) readout and are carried as evidence on KE:ke-inhibited-apoptosis.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Untreated culture medium, 24 hours (control) EXPOSURE:ferecatu-untreated-24h |
— | — | 24 hour |
| A23187 (calcimycin) 3 uM for 20 hours EXPOSURE:ferecatu-a23187-3um-20h |
Calcimycin CHEBI:3305 |
3 micromolar | 20 hour |
| PM2.5-AW 10 ug/cm2 for 4 hours, then A23187 3 uM for a further 20 hours EXPOSURE:ferecatu-pm25aw-10-4h-then-a23187 |
fine respirable suspended particulate matter ENVO:01000415 |
10 microgram per square centimeter | 4 hour |
| PM2.5-AW 1-50 ug/cm2 for 4 hours (dose-response series), then A23187 3 uM for a further 20 hours EXPOSURE:ferecatu-pm25aw-1to50-4h-then-a23187 |
fine respirable suspended particulate matter ENVO:01000415 |
microgram per square centimeter (range 1 to 50) | 4 hour |
Outputs
| Group | Output | Description |
|---|---|---|
| control | Untreated 16HBE control OX:ferecatu-pm25-a23187-16hbe-output-control · under EXPOSURE:ferecatu-untreated-24h |
|
| treated | 16HBE exposed to A23187 alone OX:ferecatu-pm25-a23187-16hbe-output-a23187 · under EXPOSURE:ferecatu-a23187-3um-20h |
|
| treated | 16HBE pretreated with PM2.5-AW at the standard 10 ug/cm2 dose before A23187 OX:ferecatu-pm25-a23187-16hbe-output-pm25-a23187 · under EXPOSURE:ferecatu-pm25aw-10-4h-then-a23187 |
|
| treated | 16HBE pretreated with PM2.5-AW across the 1-50 ug/cm2 dose series before A23187 OX:ferecatu-pm25-a23187-16hbe-output-pm25-dose-series-a23187 · under EXPOSURE:ferecatu-pm25aw-1to50-4h-then-a23187 |
Evidence
by four parameters and expressed as percentage of 16HBE cells showing ΔΨm drop (DiOC6(3) low) and ROS production (HE->Eth high) or PS exposure (Annexin V+) and plasma membrane permeabilization (PI high).
Confirms ROS production was one of the four parameters quantified in this pretreatment experiment, which is what makes it an oxidative stress assay.
After a 4 h pretreatment with PM 2.5-AW (10 μg/cm2), 16HBE cells were exposed to different inducers of cell death for another 20 h such as mitochondrial respiratory chain inhibitors (rotenone (Rot, 5 μM), antimycin A (AMA, 25 μg/ml) and oligomycin (Omy, 5 μM)), calcium ionophores (ionomycin (Iono, 0.5 μM) and A23187, 3 μM), protein kinases inhibitor (staurosporine STS, 1 μM) and oxidative stress activator
Gives the exposure design recorded in the conditions above: 4 h PM2.5-AW at 10 ug/cm2, then 20 h with A23187 at 3 uM.
Conversely, a 4 hour-pretreatment with PM2.5 prevent mitochondria-driven apoptosis triggered by broad spectrum inducers (A23187, staurosporine and oligomycin) by reducing the mitochondrial transmembrane potential loss, the subsequent ROS production, phosphatidylserine externalization, plasma membrane permeabilization and typical morphological outcomes
The assay's result on the ROS parameter: PM2.5 pretreatment lowered the ROS production that follows the mitochondrial transmembrane potential loss.
mitochondrial and plasma membranes alterations of apoptosis at concentrations as high as 5 μM of A23187
The protection held across the A23187 dose range, up to 5 uM - the inducer dose-response arm of this assay.
Particle pretreatment was performed with different doses (1-50 μg/cm2) 4 h prior to induction of apoptosis by 3 μM of A23187.
Gives the particle dose-response pretreatment arm recorded above, alongside the standard 10 ug/cm2 condition.
EGFR signaling assays
Amphiregulin and GM-CSF secretion from 16HBE cells after 4 h or 24 h PM2.5 exposure
Subconfluent 16HBE cells were exposed to PM2.5 (10 ug/cm2) for 4 h or 24 h and the released EGFR ligand amphiregulin and the cytokine GM-CSF were measured by ELISA in particle-cleared supernatants. Secretion of both appeared only at 24 h - after the antiapoptotic effect, which is established within the 4 h pretreatment. This timing is the paper's argument that the EGFR/proinflammatory arm is not the antiapoptotic mechanism. The ELISA concentrations are reported only in Figure 5A, so no measurement slots are filled.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Untreated culture medium, 24 hours (control) EXPOSURE:ferecatu-untreated-24h |
— | — | 24 hour |
| PM2.5 10 ug/cm2 for 4 hours EXPOSURE:ferecatu-pm25-10-4h |
fine respirable suspended particulate matter ENVO:01000415 |
10 microgram per square centimeter | 4 hour |
| PM2.5 10 ug/cm2 for 24 hours EXPOSURE:ferecatu-pm25-10-24h |
fine respirable suspended particulate matter ENVO:01000415 |
10 microgram per square centimeter | 24 hour |
Outputs
| Group | Output | Description |
|---|---|---|
| control | Untreated 16HBE control supernatant EGFR:ferecatu-ar-gmcsf-16hbe-output-control · under EXPOSURE:ferecatu-untreated-24h |
|
| treated | 16HBE supernatant after 4 h PM2.5 exposure EGFR:ferecatu-ar-gmcsf-16hbe-output-pm25-4h · under EXPOSURE:ferecatu-pm25-10-4h |
|
| treated | 16HBE supernatant after 24 h PM2.5 exposure EGFR:ferecatu-ar-gmcsf-16hbe-output-pm25-24h · under EXPOSURE:ferecatu-pm25-10-24h |
Evidence
Subconfluent 16HBE cells were exposed to PM 2.5-AW for 4 h or 24 h and supernatants were recovered
Gives the two exposure durations and the sample type this assay records.
of Amphiregulin (AR) and GM-CSF released were evaluated with an enzyme-linked immunosorbent assay kit (ELISA, R&D Systems Europe; Abingdon, UK)
Names the two analytes and the ELISA method recorded in this assay's protocols.
Results showed that AR and GM-CSF secretion occur only after a 24 h exposure, which is in agreement with previous studies published on PM 2.5-VW and PM 2.5-AS
The assay's result: amphiregulin and GM-CSF rose at 24 h but not at 4 h, which is why the 4 h and 24 h output records are kept apart.
Gene expression assays
AhR protein in 16HBE cells after AhR siRNA silencing
16HBE cells were transfected with 10 nM AhR siRNA or a non-silencing control siRNA and blotted for AhR 48 h later, with actin as the loading reference, to confirm the knockdown before the apoptosis readouts. The paper shows the blot (Figure 7B upper panel) but reports no densitometric values, so protein_level is omitted rather than estimated from the image.
Exposure conditions
| Condition | Agent | Concentration | Duration |
|---|---|---|---|
| Non-silencing control siRNA 10 nM, 48 hours (transfection control) EXPOSURE:ferecatu-sirna-nonsilencing-48h |
— | 10 nanomolar | 48 hour |
| AhR siRNA 10 nM, 48 hours EXPOSURE:ferecatu-sirna-ahr-48h |
— | 10 nanomolar | 48 hour |
Outputs
| Group | Output | Description |
|---|---|---|
| vehicle_control | AhR protein in non-silencing siRNA 16HBE cells GENE:ferecatu-ahr-wb-16hbe-output-nonsilencing · under EXPOSURE:ferecatu-sirna-nonsilencing-48h |
|
| treated | AhR protein in AhR siRNA 16HBE cells GENE:ferecatu-ahr-wb-16hbe-output-sirna-ahr · under EXPOSURE:ferecatu-sirna-ahr-48h |
Evidence
Then, 10 nM of AhR siRNA (Hs_AHR_6 AlexaFluor-647, Ref SI03043971, Qiagen) or control non-silencing siRNA (AllStars Neg AlexaFluor-647, Ref 1027287, Qiagen)
Gives the siRNA concentration and the two constructs recorded as this assay's two exposure conditions.
validation of AhR silencing by western blot (Figure 7B upper panel)
The assay's result: the Western blot confirmed that the siRNA lowered AhR protein.
the primary antibodies used were: mouse-monoclonal anti-AhR (WH0000196M2, Sigma) and anti-Actin (A5441, Sigma).
Names the AhR antibody and the actin normalization reference recorded in this assay's Western blot protocol.
Key events
Increased oxidative stress
even when 16HBE cells were exposed for longer times to PM 2.5-AW (1-50 μg/cm2), no significative increase of apoptotic parameters was observed
Superoxide anion generation (hydroethidine) was one of the apoptotic parameters quantified, so this result shows that PM2.5-AW at 1-50 ug/cm2 did not increase oxidative stress in 16HBE cells even at 48-72 h.
Conversely, a 4 hour-pretreatment with PM2.5 prevent mitochondria-driven apoptosis triggered by broad spectrum inducers (A23187, staurosporine and oligomycin) by reducing the mitochondrial transmembrane potential loss, the subsequent ROS production, phosphatidylserine externalization, plasma membrane permeabilization and typical morphological outcomes
PM2.5 pretreatment reduced rather than increased ROS production downstream of the apoptosis inducers, which is the opposite direction to this key event.
AhR pathway activation
Finally, the activation or silencing of the aryl hydrocarbon receptor (AhR) showed that it is involved into the molecular mechanism of the antiapoptotic effect of PM2.5 at the mitochondrial checkpoint of apoptosis.
Both pharmacological activation and genetic silencing of AhR changed the PM2.5 response, placing AhR activation in the mechanism.
Note that the particle-coupled PAH are bioavailable in our system since CYP1A1 mRNA and its enzymatic activity were increased
Induction of CYP1A1, a canonical AhR target gene, is direct evidence that the particle-bound PAH reached and activated the AhR pathway in these cells.
beta-NF (20 μg/ml) used prior to A23178 significantly reduced the amount of apoptotic cells (31% reduction of DiOC6(3) low), and further improved the protection conferred by PM 2.5 exposure (54% vs. 37% reduction of DioC6(3) low).
The AhR agonist beta-naphthoflavone reproduced and amplified the PM2.5 effect, showing that activating this pathway is sufficient to protect the mitochondrial checkpoint.
exposure (25% vs. 37% reduction of DiOC6(3) low), although it did not noticeably modify the apoptotic effect of A23187.
The AhR antagonist alpha-naphthoflavone cut the PM2.5 protection from 37% to 25% without affecting A23187 on its own, so the loss is specific to the AhR-dependent arm.
Then, intracellular PAH can target and activate the aryl hydrocarbon receptor (AhR).
The authors' mechanistic model names PAH desorbed from endocytosed particles as the AhR ligands.
EGFR activation
Results showed that AR and GM-CSF secretion occur only after a 24 h exposure, which is in agreement with previous studies published on PM 2.5-VW and PM 2.5-AS
PM2.5 exposure does elicit secretion of the EGFR ligand amphiregulin from 16HBE cells, confirming EGFR pathway engagement - but as a late (24 h) event.
The use of recombinant EGF and specific inhibitor led us to rule out the involvement of the classical EGFR signaling pathway as well as the proinflammatory cytokines secretion.
Neither adding recombinant EGF nor inhibiting the receptor altered the response, so EGFR activation is not the step through which PM2.5 suppresses apoptosis here.
Inhibited apoptosis
Conversely, a 4 hour-pretreatment with PM2.5 prevent mitochondria-driven apoptosis triggered by broad spectrum inducers (A23187, staurosporine and oligomycin) by reducing the mitochondrial transmembrane potential loss, the subsequent ROS production, phosphatidylserine externalization, plasma membrane permeabilization and typical morphological outcomes
A 4 h PM2.5 pretreatment suppressed every measured hallmark of mitochondria-driven apoptosis, which is this key event.
(33% reduction of DiOC6(3) low), the calcium ionophore A23187 (35% reduction of DiOC6(3) low) and staurosporine (44% reduction of DiOC6(3) low), but not by ionomycin, rotenone,
Quantifies the inhibition in 16HBE cells - 33% for oligomycin, 35% for A23187, 44% for staurosporine - and shows it is selective, with no protection against ionomycin, rotenone, antimycin A or H2O2.
experiments performed in NCI-H292 and NHBE cells showed that PM 2.5-AW also reduced apoptosis induced by A23187 or STS but not by H2O2
The inhibition is not a quirk of one immortalized line: it reproduces in the NCI-H292 carcinoma line and in primary NHBE cells.
the antiapoptotic effect of PM 2.5 -AW was partially efficient at 10 μg/cm 2 and totally effective for concentrations beyond 25 μg/cm 2
Gives the particle dose-dependence of the inhibition: partial at the standard 10 ug/cm2 dose, complete above 25 ug/cm2.
but PM 2.5 -AW (50 μg/cm 2) totally counteracted the cellular volume decrease
The morphological arm of the same inhibition: A23187 alone shrank the cells to 66.2% of control volume, and PM2.5-AW at 50 ug/cm2 fully blocked that apoptotic cell-volume loss.
Instead, the water-soluble fraction, washed particles and organic compounds such as polycyclic aromatic hydrocarbons (PAH) could mimic this antiapoptotic activity.
Identifies which particle fractions carry the inhibitory activity: the water-soluble fraction, the washed particles themselves, and the adsorbed organic PAH.
Except for B(b)F, all the other PAH reduced the amount of apoptosis induced by A23187, similar to that of PM 2.5 pretreatment and B(a)P seems to be the most efficient
Four of the five heavy PAH tested reproduced the inhibition on their own, with benzo[a]pyrene the most potent.
Airway inflammation
The PM2.5-antiapoptotic effect in addition to the well-documented inflammatory response might explain the maintenance of a prolonged inflammation state induced after pollution exposure and might delay repair processes of injured tissues.
The authors place their finding alongside the established inflammatory response to PM2.5, proposing that apoptosis resistance is what sustains airway inflammation after exposure.
Airway remodeling
Thus, mechanisms involved in airway remodelling might be the excessive cell proliferation as well as the resistance to the apoptotic cell death.
The paper names resistance to apoptotic cell death as one of the mechanisms behind airway remodeling, which is why this tissue-level key event is relevant here.
Key-event relationships
AhR pathway activation leads to inhibited apoptosis in bronchial epithelial cells
PAH desorbed from PM2.5 activate AhR, and AhR activation accounts for part of the protection of the mitochondrial apoptosis checkpoint. Three independent manipulations agree: the agonist beta-naphthoflavone protected on its own and raised PM2.5 protection from 37% to 54%, the antagonist alpha-naphthoflavone cut it to 25%, and AhR siRNA cut it from 27% to 18%. Because neither the antagonist nor the siRNA abolished the protection, the authors conclude AhR only partially contributes and another pathway must also be involved - hence moderate, not strong, support.
Finally, the activation or silencing of the aryl hydrocarbon receptor (AhR) showed that it is involved into the molecular mechanism of the antiapoptotic effect of PM2.5 at the mitochondrial checkpoint of apoptosis.
States the causal link directly: AhR status determines whether PM2.5 suppresses apoptosis at the mitochondrial checkpoint.
AhR silencing significantly reduced the protection triggered by PM 2.5 (18% vs. 27% reduction of DiOC(6)3 low) alike the antagonist (alpha-NF) did.
Genetic loss of AhR weakened the downstream inhibition of apoptosis, the key necessity test for this relationship.
these results suggest that AhR partially contributes to the antiapoptotic effect of PM 2.5 exposure.
The authors' own summary of the relationship's strength: real but partial, which is why evidence_support is moderate.
some of them might be mitochondrial MMP regulators (dotted arrow), thus might protect the cell from apoptosis induced by A23187, staurosporin (STS) or oligomycin (Omy).
Proposes the intermediate step - AhR target genes acting as mitochondrial membrane permeabilization regulators - linking AhR activation to the apoptosis block.
EGFR activation leads to inhibited apoptosis in bronchial epithelial cells
Tested and ruled out. Amphiregulin and GM-CSF secretion appeared only at 24 h, after the antiapoptotic effect was already established, and neither recombinant EGF nor the EGFR inhibitor AG1478 altered the reduction of A23187-induced apoptosis. Recorded as a relationship with REFUTE evidence so the negative result is not re-tested by the next curator; evidence_support is weak because the paper argues against the link rather than for it.
we used a recombinant EGF ligand (rEGF) or the inhibitor of EGF receptor (AG1478, Figure 5B) to show that none of the two compounds modifies the reduction of A23187-induced apoptosis.
Driving the receptor with ligand and blocking it with AG1478 both left the apoptosis inhibition unchanged, so EGFR activation is not the upstream step.
Results showed that AR and GM-CSF secretion occur only after a 24 h exposure, which is in agreement with previous studies published on PM 2.5-VW and PM 2.5-AS
Timing argues against the link: the EGFR-ligand response is a late event while the apoptosis inhibition is established within the 4 h pretreatment.
The use of recombinant EGF and specific inhibitor led us to rule out the involvement of the classical EGFR signaling pathway as well as the proinflammatory cytokines secretion.
The authors state the rule-out explicitly for both the EGFR pathway and the proinflammatory cytokine arm.
Inhibited apoptosis leads to sustained airway inflammation
The authors' proposed in vivo consequence of their in vitro finding: apoptosis resistance on top of the established inflammatory response might maintain a prolonged inflammation state after pollution exposure. Hedged ("might explain") and not tested in this paper, so support is weak and the relationship is indirect.
The PM2.5-antiapoptotic effect in addition to the well-documented inflammatory response might explain the maintenance of a prolonged inflammation state induced after pollution exposure and might delay repair processes of injured tissues.
States the hypothesised causal chain from the antiapoptotic effect to prolonged airway inflammation and delayed tissue repair.
Inhibited apoptosis leads to airway remodeling
Background reasoning the paper's result speaks to: airway remodeling after chronic particle exposure may arise from excessive proliferation and from resistance to apoptotic cell death. This paper supplies the apoptosis-resistance half in vitro but does not measure remodeling, so support is weak and the relationship is indirect.
Thus, mechanisms involved in airway remodelling might be the excessive cell proliferation as well as the resistance to the apoptotic cell death.
Names resistance to apoptotic cell death as a mechanism of airway remodeling, which is the relationship asserted here.
Protocols
Four-parameter flow cytometric apoptosis panel in bronchial epithelial cells
Apoptosis hallmarks recommended by the Nomenclature Committee on Cell Death were quantified by flow cytometry: 3,3-dihexyloxacarbocyanine iodide (DiOC6(3), 2 nM) for the mitochondrial transmembrane potential, hydroethidine (HE, 2 uM) for superoxide anion generation, Annexin V-FITC for phosphatidylserine exposure, and propidium iodide (PI, 10 ug/ml) for plasma membrane permeabilization. Percentage induction of apoptosis was computed relative to the apoptotic fraction of control cells.
Amphiregulin ELISA on bronchial epithelial cell supernatants
Subconfluent 16HBE cells were exposed to PM2.5-AW for 4 h or 24 h; supernatants were recovered, centrifuged at 15,000 x g for 15 min at 4 degrees C to pellet particles, frozen at -80 degrees C, and assayed for released amphiregulin.
GM-CSF ELISA on bronchial epithelial cell supernatants
Granulocyte monocyte colony-stimulating factor released into the supernatant of PM2.5-AW-exposed subconfluent 16HBE cells (4 h or 24 h) was measured on the same particle-cleared, frozen supernatants used for amphiregulin.
AhR gene silencing by fluorescent siRNA in 16HBE cells
16HBE cells were seeded at 2 x 10^4 cells/cm2 and transfected overnight later with 10 nM AhR siRNA (Hs_AHR_6 AlexaFluor-647, SI03043971, Qiagen) or a non-silencing control siRNA (AllStars Neg AlexaFluor-647, 1027287, Qiagen) using HiPerFect. The AlexaFluor-647 tag allowed transfected cells to be gated by flow cytometry. Experiments were run 48 h after transfection.
Western blot for AhR protein in 16HBE cells
Whole-cell lysates from siRNA-transfected 16HBE cells were blotted for AhR and for actin as the loading reference; immunoreactive bands were detected by chemiluminescence. The blot is qualitative - the paper reports no densitometric values - and served to confirm that the siRNA silenced AhR.